F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma

Oral Oncology

Volumn 43, Issue 7, 2007, Pages 686-692

  Lee, Jong Cheol ^a   Kim, Jae Seung ^a   Lee, Jeong Hyun ^a   Nam, Soon Yuhl ^a   Choi, Seung Ho ^a   Lee, Sang wook ^a   Kim, Sung Bae ^a   Kim, Sang Yoon ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

FDG PET; Head and neck; Recurrence; Squamous cell carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FOLLOW UP; HEAD AND NECK CARCINOMA; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 34447319631     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.08.006     Document Type: Article

References (18)

1. McGuirt W.F., Greven K., Williams III D., Keyes Jr. J.W., Watson N., Cappellari J.O., et al. PET scanning in head and neck oncology: a review. Head Neck 20 (1998) 208-215
2. 18F-fluoro-2-deoxy-d-glucose positron emission tomography. Laryngoscope 109 (1999) 970-975
3. Lonneux M., Lawson G., Ide C., Bausart R., Remacle M., and Pauwels S. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope 110 (2000) 1493-1497
4. Ware R.E., Matthews J.P., Hicks R.J., Porceddu S., Hogg A., Rischin D., et al. Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck. Head Neck 26 (2004) 1008-1017
5. 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. J Nucl Med 45 (2004) 1669-1676
6. 18F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 20 (2002) 4199-4208
7. Minn H., Paul R., and Ahonen A.J. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med 29 (1988) 1521-1525
8. Greven K.M., Williams III D.W., McGuirt Sr. W.F., Harkness B.A., D'Agostino Jr. R.B., Keyes Jr. J.W., et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 23 (2001) 942-946
9. Lowe V.J., Boyd J.H., Dunphy F.R., Kim H., Dunleavy T., Collins B.T., et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 18 (2000) 651-658
10. Goerres G.W., Schmid D.T., Bandhauer F., Huguenin P.U., von Schulthess G.K., Schmid S., et al. Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 130 (2004) 105-109
11. 18FDG-PET. Oral Oncol 41 (2005) 390-395
12. Greene F.L., Page D.L., Fleming I.D., Fritz A.G., Balch C.M., Haller D.G., et al. AJCC cancer staging manual. 6th ed. (2002), Springer-Verlag, New York
13. Manolidis S., Donald P.J., Volk P., and Pounds T.R. The use of positron emission tomography scanning in occult and recurrent head and neck cancer. Acta Otolaryngol Suppl 534 (1998) 1-11
14. Terhaard C.H., Bongers V., van Rijk P.P., and Hordijk G.J. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer. Head Neck 23 (2001) 933-941
15. Conessa C., Herve S., Foehrenbach H., and Poncet J.L. FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas. Ann Otol Rhinol Laryngol 113 (2004) 628-635
16. Ryan W.R., Fee Jr. W.E., Le Q.T., and Pinto H.A. Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope 115 (2005) 645-650
17. Bourhis J., Dendale R., Hill C., Bosq J., Janot F., Attal P., et al. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks. Int J Radiat Oncol Biol Phys 35 (1996) 471-476
18. Tabor M.P., Brakenhoff R.H., Ruijter-Schippers H.J., Kummer J.A., Leemans C.R., and Braakhuis B.J.M. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin Cancer Res 10 (2004) 3607-3613